JP2007508361A5 - - Google Patents

Download PDF

Info

Publication number
JP2007508361A5
JP2007508361A5 JP2006534800A JP2006534800A JP2007508361A5 JP 2007508361 A5 JP2007508361 A5 JP 2007508361A5 JP 2006534800 A JP2006534800 A JP 2006534800A JP 2006534800 A JP2006534800 A JP 2006534800A JP 2007508361 A5 JP2007508361 A5 JP 2007508361A5
Authority
JP
Japan
Prior art keywords
group
formula
compound
compound according
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006534800A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007508361A (ja
JP4853918B2 (ja
Filing date
Publication date
Priority claimed from FR0312165A external-priority patent/FR2861076B1/fr
Application filed filed Critical
Publication of JP2007508361A publication Critical patent/JP2007508361A/ja
Publication of JP2007508361A5 publication Critical patent/JP2007508361A5/ja
Application granted granted Critical
Publication of JP4853918B2 publication Critical patent/JP4853918B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006534800A 2003-10-17 2004-10-15 グリシン輸送阻害剤としての三環式化合物の使用 Expired - Fee Related JP4853918B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0312165 2003-10-17
FR0312165A FR2861076B1 (fr) 2003-10-17 2003-10-17 Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
PCT/FR2004/002643 WO2005037783A2 (fr) 2003-10-17 2004-10-15 Composes tricycliques comme inhibiteurs de transport de glycine

Publications (3)

Publication Number Publication Date
JP2007508361A JP2007508361A (ja) 2007-04-05
JP2007508361A5 true JP2007508361A5 (cg-RX-API-DMAC7.html) 2011-04-21
JP4853918B2 JP4853918B2 (ja) 2012-01-11

Family

ID=34385252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006534800A Expired - Fee Related JP4853918B2 (ja) 2003-10-17 2004-10-15 グリシン輸送阻害剤としての三環式化合物の使用

Country Status (32)

Country Link
US (3) US7288656B2 (cg-RX-API-DMAC7.html)
EP (1) EP1680421B1 (cg-RX-API-DMAC7.html)
JP (1) JP4853918B2 (cg-RX-API-DMAC7.html)
KR (1) KR101125305B1 (cg-RX-API-DMAC7.html)
CN (2) CN1882587B (cg-RX-API-DMAC7.html)
AT (1) ATE386036T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004281217B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0415489A (cg-RX-API-DMAC7.html)
CA (1) CA2542647C (cg-RX-API-DMAC7.html)
CR (1) CR8342A (cg-RX-API-DMAC7.html)
CY (1) CY1108925T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004011806T2 (cg-RX-API-DMAC7.html)
DK (1) DK1680421T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP066511A (cg-RX-API-DMAC7.html)
ES (1) ES2300837T3 (cg-RX-API-DMAC7.html)
FR (1) FR2861076B1 (cg-RX-API-DMAC7.html)
HR (1) HRP20080186T3 (cg-RX-API-DMAC7.html)
IL (1) IL174940A (cg-RX-API-DMAC7.html)
MA (1) MA28099A1 (cg-RX-API-DMAC7.html)
ME (1) ME00111B (cg-RX-API-DMAC7.html)
NO (1) NO335462B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ547163A (cg-RX-API-DMAC7.html)
OA (1) OA13317A (cg-RX-API-DMAC7.html)
PL (1) PL1680421T3 (cg-RX-API-DMAC7.html)
PT (1) PT1680421E (cg-RX-API-DMAC7.html)
RS (2) RS20060314A (cg-RX-API-DMAC7.html)
RU (1) RU2346945C2 (cg-RX-API-DMAC7.html)
SG (1) SG147435A1 (cg-RX-API-DMAC7.html)
TN (1) TNSN06110A1 (cg-RX-API-DMAC7.html)
UA (1) UA81186C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005037783A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200603861B (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842804B1 (fr) 2002-07-29 2004-09-03 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861071B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
FR2861074B1 (fr) * 2003-10-17 2006-04-07 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861076B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
JP2007530664A (ja) * 2004-03-30 2007-11-01 ペインセプター ファーマ コーポレーション ゲートイオンチャンネルを調節するための組成物及び方法
FR2906251B1 (fr) * 2006-09-22 2008-11-07 Sanofi Aventis Sa Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique
US11817637B2 (en) 2006-11-18 2023-11-14 Rfmicron, Inc. Radio frequency identification (RFID) moisture tag(s) and sensors with extended sensing via capillaries
US9582981B2 (en) 2014-10-08 2017-02-28 Rfmicron, Inc. Radio frequency identification (RFID) moisture tag(s) and sensors with extended sensing via capillaries
TW200911808A (en) * 2007-07-23 2009-03-16 Astrazeneca Ab Novel compounds
MX2009014235A (es) 2007-08-22 2010-04-27 Abbott Gmbh & Co Kg 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
ES2397764T3 (es) 2008-04-01 2013-03-11 Abbott Gmbh & Co. Kg Tetrahidroisoquinolinas, composiciones farmacéuticas que las contienen, y su uso en terapia
BRPI0922787A2 (pt) * 2008-12-04 2017-07-11 Sanofi Sa Formas polimórficas de um derivado da azabiciclo-trifluorometil benzamida
JP2012516326A (ja) * 2009-01-28 2012-07-19 アストラゼネカ・アクチエボラーグ 2−アザ−ビシクロ[2.2.1]ヘプタン化合物及びそれらの使用
WO2010087761A1 (en) * 2009-01-28 2010-08-05 Astrazeneca Ab 2-aza-bicyclo[2.2.2]octane compounds and uses thereof
FR2941954B1 (fr) * 2009-02-10 2011-04-08 Sanofi Aventis Derives de n-°(6-aza-bicyclo°3.2.1!oct-1-yl)-aryl-methyl! benzamide, leur preparation et leur application en therapeutique
FR2941953B1 (fr) * 2009-02-10 2011-04-08 Sanofi Aventis Derives de n-°(2-aza-bicyclo°2.1.1!hex-1-yl)-benzamide, leur preparation et leur application en therapeutique
AR075442A1 (es) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
TW201038569A (en) 2009-02-16 2010-11-01 Abbott Gmbh & Co Kg Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
FR2943059A1 (fr) * 2009-03-16 2010-09-17 Sanofi Aventis Derives de n-°6-aza-bicyclo°3.2.1!oct-5-yl)-aryl-methyl!- heterobenzamide,leur preparation et leur application en therapeutique
FR2943056A1 (fr) * 2009-03-16 2010-09-17 Sanofi Aventis Derives de n-°2-aza-bicyclo°2.1.1!hex-1-yl)-aryl-methyl!- heterobenzamide, leur preparation et leur application en therapeutique
RU2011141778A (ru) * 2009-03-16 2013-04-27 Санофи Производные n-[(2-азабицикло[2.1.1]гекс-1-ил)арилметил]гетеробензамида, их получение и их применение в терапии
FR2944284A1 (fr) * 2009-04-14 2010-10-15 Sanofi Aventis Derives de n-°7-aza-bicyclo°2.2.1!hept-1-yl)-aryl-methyl! -benzamide, leur preparation et leur application en therapeutique
US8153653B2 (en) 2010-06-22 2012-04-10 Hoffmann-La Roche Inc. Amido-tropane derivatives
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) * 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en) 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
WO2013020930A1 (en) 2011-08-05 2013-02-14 Abbott Gmbh & Co. Kg Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
WO2013072520A1 (en) 2011-11-18 2013-05-23 AbbVie Deutschland GmbH & Co. KG N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
TR201806764T4 (tr) * 2011-11-29 2018-06-21 Vivozon Inc Yeni benzamid türevi ve bunun kullanımı.
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
KR20160062164A (ko) 2013-10-17 2016-06-01 아비에 도이치란트 게엠베하 운트 콤파니 카게 아미노크로만, 아미노티오크로만 및 아미노-1,2,3,4-테트라하이드로퀴놀린 유도체, 이들을 포함하는 약제학적 조성물, 및 치료에서 이들의 용도
CA2924699A1 (en) 2013-10-17 2015-04-23 AbbVie Deutschland GmbH & Co. KG Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9550754B2 (en) 2014-09-11 2017-01-24 AbbVie Deutschland GmbH & Co. KG 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
JP6906227B2 (ja) * 2017-08-18 2021-07-21 国立大学法人千葉大学 ハロゲン結合ドナー/有機塩基複合型化合物及び酸塩基複合触媒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066662A (en) * 1973-12-14 1978-01-03 Science Union Et Cie., Societe Francaise De Recherche Medicale N-substituted-2-aminomethyl-3-azabicyclo(3,3,0)octane compounds
CA1223873A (en) * 1982-04-14 1987-07-07 Francis D. King Pharmaceutically active compounds
ES2051753T3 (es) * 1986-12-16 1994-07-01 Robins Co Inc A H N-(1-azabiciclo(2.2.2)octo-3-il) benzamidas y tiobenzamidas ansioliticas.
GB8720805D0 (en) * 1987-09-04 1987-10-14 Naylor R J 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
EP1058684A1 (en) * 1998-03-06 2000-12-13 Janssen Pharmaceutica N.V. Glycine transport inhibitors
FR2861076B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique

Similar Documents

Publication Publication Date Title
JP2007508361A5 (cg-RX-API-DMAC7.html)
JP2007508360A5 (cg-RX-API-DMAC7.html)
RU2470011C2 (ru) Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов
RU2006116885A (ru) Производные n-фенил(пиперидин-2-ил)метил-бензамида, способ получения указанных соединений и их применение в терапии
JP2002523491A5 (cg-RX-API-DMAC7.html)
JP2007516941A5 (cg-RX-API-DMAC7.html)
JP2007508358A5 (cg-RX-API-DMAC7.html)
JP2010504344A5 (cg-RX-API-DMAC7.html)
JP2007533722A5 (cg-RX-API-DMAC7.html)
JP2002523508A5 (cg-RX-API-DMAC7.html)
JP2014508811A5 (cg-RX-API-DMAC7.html)
JP2006507220A5 (cg-RX-API-DMAC7.html)
JP2007519649A5 (cg-RX-API-DMAC7.html)
JP2004518763A5 (cg-RX-API-DMAC7.html)
JP2011527333A5 (cg-RX-API-DMAC7.html)
RU2009142434A (ru) Производные триазолопиридин-карбоксамидов и триазолопиримидин-карбоксамидов, их получение и их применение в терапии
JP2008539268A5 (cg-RX-API-DMAC7.html)
JP2008540554A5 (cg-RX-API-DMAC7.html)
JP2011524850A5 (cg-RX-API-DMAC7.html)
JP2002523506A5 (cg-RX-API-DMAC7.html)
JP2002525280A5 (cg-RX-API-DMAC7.html)
CA2702482A1 (en) Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
JP2014505107A5 (cg-RX-API-DMAC7.html)
JP2004532823A5 (cg-RX-API-DMAC7.html)
JP2014532730A5 (ja) オピオイド受容体の調節物質およびそれを含む薬学的組成物